China SXT Pharmaceuticals (SXTC) Current Leases (2023 - 2025)

China SXT Pharmaceuticals' Current Leases history runs 3 years deep, the most recent figure standing at $64118.0 for Q3 2025.

• In Q3 2025, Current Leases rose 110.91% year-over-year to $64118.0; the TTM figure through Sep 2025 stood at $64118.0 (up 110.91% YoY), while the FY2025 annual figure was $61229.0, up 5.01% from the prior year.
• Current Leases was $64118.0 for Q3 2025 at China SXT Pharmaceuticals, up from $61229.0 in the prior quarter.
• In the past five years, Current Leases ranged from a high of $64118.0 in Q3 2025 to a low of $30401.0 in Q3 2024.
• Historically, Current Leases has averaged $54719.7 across 3 years, with a median of $58199.5 in 2023.
• The sharpest annual moves came in 2024 and 2025: Current Leases slumped 45.88% in 2024, then surged 110.91% in 2025.
• A 3-year view of Current Leases shows it stood at $56171.0 in 2023, then plunged by 45.88% to $30401.0 in 2024, then surged by 110.91% to $64118.0 in 2025.
• The last three Current Leases figures came in at $64118.0 (Q3 2025), $61229.0 (Q1 2025), and $30401.0 (Q3 2024), per Business Quant data.